The Listed Podcast
Top Stories ARU — Arafura launches A$350M placement and A$25M SPP at A$0.26/share to fully fund Nolans Rare Earths Project The day after making its Final Investment Decision, Arafura Rare Earths has launched a two-tranche A$350 million institutional placement at A$0.26 per share to fully fund the equity component of the Nolans Project. Hancock Prospecting is anchoring the raise with an A$85 million commitment, taking a roughly 17.5% post-placement stake — serious institutional conviction from one of Australia’s most credible mining investors. Combined with prior equity raises and binding commitments from sovereign-backed institutions across four nations, pro forma cash hits approximately A$911 million upon settlement. A A$25 million SPP is also open for eligible retail shareholders. With 93% of binding offtake targets secured and construction starting September 2026, Australia’s first integrated ore-to-oxide rare earths project is now fully funded. GYG — GYG exits US market immediately, takes US$30-40M hit but upgrades Australia EBITDA guidance to $85M Guzman y Gomez is pulling the plug on all US operations in Chicago with immediate effect — the company says sales momentum was insufficient and financial performance missed every hurdle. The exit will cost GYG a one-off P&L charge of US$30 to $40 million in FY26, though cash exit costs are capped at US$15 million — painful but contained. The more important number for investors is the silver lining: Australian segment underlying EBITDA guidance upgraded to approximately $85 million for FY26, representing 29% growth on the prior year. The domestic business is clearly firing and the strategic focus is now squarely back on Australia and its profitable international master franchise markets in Singapore and Japan. STG — Straker Limited halted pending investigation into US bank account transaction anomalies Straker Limited has called an immediate trading halt while it investigates transaction anomalies discovered in its US bank accounts. No further details have been disclosed, but a halt triggered by potential financial irregularities — rather than a routine capital raise or corporate transaction — is a serious red flag for investors. The halt remains in place until at least Tuesday 26 May. This is one to watch very carefully over the long weekend. Mid-Tier Movers IMU — Imugene’s off-the-shelf CAR T therapy azer-cel delivered an 81% overall response rate across 16 evaluable patients with relapsed or refractory blood cancers — with 100% response rates in four subtypes including CLL and follicular lymphoma. The data has been accepted as an ASCO 2026 abstract with an oral presentation on 29 May in Chicago, a major stage for biotech visibility, and a new combination cohort pairing azer-cel with a BTK inhibitor has been opened targeting a global market worth approximately US$12 billion. MPK — Many Peaks Minerals raised A$27.5 million at $0.90 per share — only a 3.2% discount to last close — to advance its Ferké Gold Project in Côte d’Ivoire, funding a pre-feasibility study targeted for Q4 2026 and more than 35,000 metres of drilling to grow the existing 1.32 million ounce gold resource. Post-raise cash exceeds A$33 million against a market cap of roughly A$151 million — well capitalised to execute. DTI — The Morris Family Trust’s takeover of DTI Group is closing fast. The offer shuts on 29 May with no extension, the bidder already controls between 75% and 90% of shares, and if the 90% compulsory acquisition threshold is crossed the company will be delisted from the ASX entirely. Regardless of the final tally, the entire DTI board is being replaced — remaining shareholders need to act before next Friday. TUA — Tuas Limited has walked away from its acquisition of Singapore telco M1 Limited after conditions precedent failed to be met by the extended Long-Stop Date of 21 May — a deal first announced back in August 2025 has now officially lapsed. Complicating matters further, Simba Telecom is cooperating with a regulatory investigation by Singapore’s IMDA into potential breaches of telecommunications law. GRL — Godolphin Resources is spinning out its Narraburra Rare Earths Project into a new separately listed entity called Matrix Critical Minerals, with MST Financial appointed as lead manager for an ASX IPO targeted in the second half of 2026. The project hosts a 94.9 million tonne JORC resource rich in heavy rare earths dysprosium, terbium and yttrium — commodities that surged in strategic value following China’s 2025 export controls. Existing GRL shareholders are in line for an in-specie distribution plus a priority IPO allocation. VFY — Vitrafy Life Sciences hit a significant IPO milestone with its platelet cryopreservation technology exceeding all FDA and European regulatory standards in a US Army validation study — a 94.4% post-thaw platelet recovery rate using a 3% DMSO no-wash protocol. This activates the pathway to FDA medical device registration for its GUARDION platform, targeted for the first half of FY27. Rapid Fire * MYX — Mayne Pharma was awarded over $13.27 million in legal costs after successfully defending proceedings brought by Cosette Pharmaceuticals over a terminated scheme — a clean win with a meaningful cash recovery, with interest still to be determined. * MND — Monadelphous secured approximately $120 million in new contracts spanning two Rio Tinto Pilbara appointments, a battery storage project at Fortescue’s Cloudbreak mine, and a maintenance panel at Port Waratah Coal Services in Newcastle. * ORN — Orion Minerals raised $15.4 million via placement at 2.2 cents per share to fast-track its South African copper assets, including early works at the Prieska Copper Zinc Mine, while finalising a US$250 million Glencore financing facility. * AS1 — Asara Resources delivered standout gold hits at its Kada project in Guinea, including 40 metres at 4.5 g/t gold, confirming a high-grade northeast extension beyond the current resource envelope with five rigs in the ground. * FXG — Felix Gold confirmed near-surface gold and antimony mineralisation in Alaska, with a best intercept of 29.26 metres at 2.16 g/t gold from just 13.4 metres depth and antimony grades up to 20.85%. * HLX — Helix Resources acquired a 50% stake in a West Pilbara gold-lithium project sitting just 4 kilometres from the Andover Lithium discovery that SQM and Hancock Prospecting acquired for roughly $1.7 billion. * PCK — PainChek raised $5.5 million in convertible notes to accelerate its US aged care expansion, capitalising on a new agreement covering 350 Sabra aged care homes in North America. * NX1 — Nexalis Therapeutics called a trading halt pending an announcement related to its existing debt funding facility. No details yet — debt facility news can cut either way and is worth monitoring from Tuesday. ASX Daily Digest · Not financial advice · Price-sensitive announcements only This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thelisteddigest.substack.com [https://thelisteddigest.substack.com?utm_medium=podcast&utm_campaign=CTA_1]
30 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de The Listed Podcast!